15
Participants
Start Date
October 31, 2022
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
BT-007 CD7 CAR-T cells
T cells purified from the peripheral blood mononuclear cell (PBMC) of subjects or subjects' relatives which depend on their conditions, transduced with 4-1BB/CD3ζ lentiviral vector, expanded in vitro for future administration.
RECRUITING
Beijing Cancer Hospital, Beijing
Lead Sponsor
Bioceltech Therapeutics, Ltd.
INDUSTRY